Publication:
Real-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study

Simple item page
dc.conference.dateDEC 09-12, 2025
dc.conference.locationSan Antonio, TX
dc.contributor.coauthorŞahin, T.
dc.contributor.coauthorMuğlu, H.
dc.contributor.coauthorBiter, S.
dc.contributor.coauthorTünbekici, S.
dc.contributor.coauthorOruç, A.
dc.contributor.coauthorGüren, A.
dc.contributor.coauthorKaban, K.
dc.contributor.coauthorAykan, M.
dc.contributor.coauthorEkinci, O.
dc.contributor.coauthorOnur, İ. Deliktaş
dc.contributor.coauthorKalem, A.
dc.contributor.coauthorAltunok, O.
dc.contributor.coauthorSeyyar, M.
dc.contributor.coauthorGüney, B.
dc.contributor.coauthorAkdoğan, O.
dc.contributor.coauthorYazıcı, M.
dc.contributor.coauthorMajidova, N.
dc.contributor.coauthorEsin, E.
dc.contributor.coauthorÇabuk, D.
dc.contributor.coauthorYazıcı, O.
dc.contributor.coauthorGürsu, R.
dc.contributor.coauthorYılmaz, M.
dc.contributor.coauthorÇınkır, H. Yeşil
dc.contributor.coauthorAteş, O.
dc.contributor.coauthorÇelik, E.
dc.contributor.coauthorKaradurmuş, N.
dc.contributor.coauthorMandel, N.
dc.contributor.coauthorBayoğlu, I.
dc.contributor.coauthorAraz, M.
dc.contributor.coauthorGöker, E.
dc.contributor.coauthorBayram, E.
dc.contributor.coauthorErdem, D.
dc.contributor.coauthorBaşaran, G.
dc.contributor.coauthorSezer, A.
dc.contributor.coauthorBilici, A.
dc.contributor.coauthorGüven, D.
dc.contributor.coauthorAksoy, S.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKemik, Fatih
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.kuauthorKöylü, Bahadır
dc.contributor.kuauthorGündüz, Şeyda
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2026-07-02T07:31:22Z
dc.date.issued2026
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1158/1557-3265.SABCS25-PS5-05-14
dc.identifier.eissn1557-3265
dc.identifier.embargoNo
dc.identifier.endpagePS50514
dc.identifier.issn1078-0432
dc.identifier.startpagePS50514
dc.identifier.urihttps://doi.org/10.1158/1557-3265.SABCS25-PS5-05-14
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33106
dc.identifier.volume32
dc.identifier.wos001720220400011
dc.languageeng
dc.publisherAmerican Association for Cancer Research
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofClinical Cancer Research
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectOncology
dc.titleReal-world outcomes of trastuzumab deruxtecan (T-DXd) in patients with HER2+metastatic breast cancer: Turkish oncology group multicenter study
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext